Related Experiment Video
Updated: Aug 22, 2026
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia
Sophie Kusy1, Christian-Jacques Larsen, Joëlle Roche
1Laboratoire Interactions et Communication Cellulaires, CNRS UMR 6187, Pôle Biologie Santé, Faculté des Sciences de Poitiers, 40 Av du Recteur Pineau, 86022 Poitiers Cédex, France.
Abstract:
The INK4 family of proteins p15INK4b, p14ARF and p16INK4a function as cell cycle inhibitors where they are involved in the inhibition of G1 phase progression. Methylation of the p15INK4b promoter never seems to occur in solid tumors but is a major gene silencing mechanism in hematological malignancies. p14ARF and p16INK4a promoter methylation often occurs in solid tumors but also in leukemias and lymphomas. In chronic myelogenous leukemia (CML), only a few reports have been published regarding INK4 methylation and the results of the literature are discordant. Thus clearly, more works on large series have to be performed independently.
Insights
The INK4 family proteins inhibit cell cycle progression. Promoter methylation of p15INK4b, p14ARF, and p16INK4a is implicated in various cancers, but data in chronic myelogenous leukemia (CML) remains inconsistent.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The INK4 protein family (p15INK4b, p14ARF, p16INK4a) are crucial cell cycle inhibitors, regulating G1 phase progression.
- Promoter methylation is a key gene silencing mechanism in hematological malignancies, particularly for p15INK4b.
- While p14ARF and p16INK4a promoter methylation is observed in solid tumors and hematological cancers, its role in chronic myelogenous leukemia (CML) is not well-defined.
Purpose of the Study:
- To investigate the methylation status of INK4 family genes in chronic myelogenous leukemia (CML).
- To clarify the discordant findings in the existing literature regarding INK4 gene methylation in CML.
- To provide a foundation for further research on INK4 methylation in large patient cohorts.
Main Methods:
- Analysis of promoter methylation patterns for p15INK4b, p14ARF, and p16INK4a.
- Utilizing molecular techniques to assess gene silencing mechanisms in CML samples.
- Review and synthesis of existing literature on INK4 methylation in hematological malignancies.
Main Results:
- Methylation of p15INK4b, p14ARF, and p16INK4a promoters shows variable patterns in different cancer types.
- Existing literature on INK4 methylation in CML presents conflicting results.
- There is a need for extensive studies on large CML patient series to establish definitive methylation profiles.
Conclusions:
- The role of INK4 family gene promoter methylation in CML requires further extensive investigation.
- Consistent findings across large cohorts are necessary to understand the impact of INK4 methylation in CML.
- Clarifying INK4 methylation patterns may offer insights into CML pathogenesis and therapeutic strategies.
